Cleared Traditional

K122167 - NEXXIS OR

K122167 is an FDA 510(k) clearance for NEXXIS OR, manufactured by Barco N.V.. The device is a Class 2 Cardiovascular device with product code DXJ cleared through the Traditional 510(k) pathway after a 273-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2013
Decision
273d
Days
Class 2
Risk

K122167 is an FDA 510(k) clearance for the NEXXIS OR. Classified as Display, Cathode-ray Tube, Medical (product code DXJ), Class II - Special Controls.

Submitted by Barco N.V. (Kortrijk, BE). The FDA issued a Cleared decision on April 22, 2013 after a review of 273 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Barco N.V. devices

FDA 510(k) Submission Details - K122167

510(k) Number K122167 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 2012
Decision Date April 22, 2013
Days to Decision 273 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
148d slower than avg
Panel avg: 125d · This submission: 273d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXJ Device Classification - Class 2, Special Controls

Product Code DXJ Display, Cathode-ray Tube, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXJ Display, Cathode-ray Tube, Medical

All 63
Devices cleared under the same product code (DXJ) and FDA review panel - the closest regulatory comparables to K122167.
SIREN EPCR SUITE
K131272 · Medusa Medical Technologies, Inc. · Jan 2014
ZOLL EPCR IOS
K131919 · ZOLL Medical Corporation · Dec 2013
SORIN CONNECT DATA MANAGEMENT SYSTEM
K131816 · Sorin Group Deutschland GmbH · Jul 2013
TLINK DATA MANAGEMENT SYSTEM (DMS)
K113214 · Terumo Cardiovascular Systems Corp. · Feb 2012
INTELLIVUE GUARDIAN SOFTWARE MODEL 866009, INTELLIVUE CL SP02 POD MODEL 865215, INTELLIVUE CL NBP POD MODEL 865216
K111905 · Philips Medizinsysteme Boeblingen GmbH, Cardiac AN · Oct 2011
RADIFORCE LARGE MONITOR SYSTEM
K112645 · Eizo GmbH · Sep 2011